Ratios Reveal: Breaking Down BridgeBio Pharma Inc (BBIO)’s Financial Health

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

BridgeBio Pharma Inc (NASDAQ: BBIO) closed the day trading at $35.82 down -3.03% from the previous closing price of $36.94. In other words, the price has decreased by -$3.03 from its previous closing price. On the day, 3.73 million shares were traded.

Ratios:

For a better understanding of BBIO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.54 and its Current Ratio is at 4.57.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on March 31, 2025, initiated with a Buy rating and assigned the stock a target price of $50.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’25 when Apuli Maricel sold 1,026 shares for $38.51 per share. The transaction valued at 39,509 led to the insider holds 147,639 shares of the business.

Lo Andrew sold 100,000 shares of BBIO for $3,849,900 on May 02 ’25. The Director now owns 105,583 shares after completing the transaction at $38.50 per share. On May 02 ’25, another insider, Lo Andrew, who serves as the Director of the company, bought 100,000 shares for $35.23 each.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 53.38.

Stock Price History:

Over the past 52 weeks, BBIO has reached a high of $39.54, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 4.32%, while the 200-Day Moving Average is calculated to be 21.62%.

Shares Statistics:

A total of 189.83M shares are outstanding, with a floating share count of 174.48M. Insiders hold about 8.11% of the company’s shares, while institutions hold 76.98% stake in the company.

Most Popular